{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:19:55Z","timestamp":1787732395097,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016334","name":"Jiangsu Provincial Medical Center","doi-asserted-by":"publisher","award":["CXZX202219"],"award-info":[{"award-number":["CXZX202219"]}],"id":[{"id":"10.13039\/501100016334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0704100"],"award-info":[{"award-number":["2018YFA0704100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0704104"],"award-info":[{"award-number":["2018YFA0704104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61821002"],"award-info":[{"award-number":["61821002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130060"],"award-info":[{"award-number":["82130060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ctro.2025.101083","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:14:07Z","timestamp":1763658847000},"page":"101083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["125I seed brachytherapy synergized with PD-1 inhibitor imparts potent antitumor immune responses in hepatocellular carcinoma"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1606-7528","authenticated-orcid":false,"given":"Peng","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhe","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Jun","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2025.101083_b0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2025.101083_b0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctro.2025.101083_b0015","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2025.101083_b0020","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1470-2045(18)30351-6","article-title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial","volume":"19","author":"Zhu","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.101083_b0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ctro.2025.101083_b0030","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/1878-0261.12658","article-title":"Radiotherapy-immunotherapy combinations - perspectives and challenges","volume":"14","author":"Mondini","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ctro.2025.101083_b0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41571-023-00782-x","article-title":"Emerging evidence for adapting radiotherapy to immunotherapy","volume":"20","author":"Galluzzi","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101083_b0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1756-9966-31-61","article-title":"125I seed irradiation induces up-regulation of the genes associated with apoptosis and cell cycle arrest and inhibits growth of gastric cancer xenografts","volume":"31","author":"Ma","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ctro.2025.101083_b0045","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jhep.2014.07.026","article-title":"Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial","volume":"61","author":"Chen","year":"2014","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.ctro.2025.101083_b0050","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.acra.2023.02.006","article-title":"Safety and efficacy of CT-guided iodine-125 brachytherapy for portal vein tumor thrombus in hepatocellular carcinoma","volume":"30","author":"Qiu","year":"2023","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ctro.2025.101083_b0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0360-3016(02)02961-9","article-title":"Surgery and permanent 125I seed paraspinal brachytherapy for malignant tumors with spinal cord compression","volume":"54","author":"Rogers","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.101083_b0060","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/JHC.S392293","article-title":"Downstaging and conversation strategy for advanced hepatocellular carcinoma with portal vein branch tumor thrombus: TACE, (125)I seed implantation, and RFA for hepatocellular carcinoma with portal vein branch tumor thrombus","volume":"10","author":"Zhao","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.ctro.2025.101083_b0065","article-title":"Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: a propensity-score analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2025.101083_b0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41577-022-00737-w","article-title":"Myeloid cell-targeted therapies for solid tumours","volume":"23","author":"Goswami","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ctro.2025.101083_b0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ctro.2025.101083_b0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1259\/bjr.74.877.740056","article-title":"A purpose-built iodine-125 irradiation plaque for low dose rate low energy irradiation of cell lines in vitro","volume":"74","author":"Aird","year":"2001","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2025.101083_b0085","first-page":"209","article-title":"Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM radiation therapy committee task group No. 43","volume":"22","author":"Nath","year":"1995","journal-title":"Am Assoc Phys Med Med Phys"},{"key":"10.1016\/j.ctro.2025.101083_b0090","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1364\/BOE.9.002871","article-title":"Effects of isoflurane anesthesia on physiological parameters in murine subcutaneous tumor allografts measured via diffuse reflectance spectroscopy","volume":"9","author":"Greening","year":"2018","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.ctro.2025.101083_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112483","article-title":"Involvement of the adenosine A(1) receptor in the hypnotic effect of rosmarinic acid","volume":"146","author":"Kim","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ctro.2025.101083_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705361","article-title":"Immunogenic cell death induction by ionizing radiation","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ctro.2025.101083_b0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1667\/RR13495.1","article-title":"Radiation as immunomodulator: implications for dendritic cell-based immunotherapy","volume":"182","author":"Roses","year":"2014","journal-title":"Radiat Res"},{"key":"10.1016\/j.ctro.2025.101083_b0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctro.2025.101083_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ctro.2025.101083_b0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bj.2017.06.003","article-title":"Macrophage biology plays a central role during ionizing radiation-elicited tumor response","volume":"40","author":"Wu","year":"2017","journal-title":"Biomed J"},{"key":"10.1016\/j.ctro.2025.101083_b0125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ctro.2025.101083_b0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ctro.2025.101083_b0135","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","article-title":"Immunological mechanisms responsible for radiation-induced abscopal effect","volume":"39","author":"Rodr\u00edguez-Ruiz","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ctro.2025.101083_b0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctro.2025.101083_b0145","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev-immunol-042617-053411","article-title":"CD4 helper and CD8 cytotoxic T cell differentiation","volume":"36","author":"Taniuchi","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ctro.2025.101083_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1205984","article-title":"Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy","volume":"14","author":"Damei","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ctro.2025.101083_b0155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy","volume":"11","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.ctro.2025.101083_b0160","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148546","article-title":"Targeting memory T cell metabolism to improve immunity","volume":"132","author":"Corrado","year":"2022","journal-title":"J Clin Invest"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:35:27Z","timestamp":1787729727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825001752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"alternative-id":["S2405630825001752"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101083","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"125I seed brachytherapy synergized with PD-1 inhibitor imparts potent antitumor immune responses in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101083"}}